Found 1216 All Conditions trials
A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
The research study is being conducted to assess the safety and efficacy of Medtronic’s Next Generation ICD lead. Duration 18 to 36 months.
The purpose of Part A of this study is to evaluate the safety, tolerability, and cardiac pharmacodynamics (the effect of the study drug on your heart) of the study drug, danicamtiv, when administered by mouth twice a day for approximately one to two weeks. Part A which may last between …
The purpose of this research study is to learn about the safety and effectiveness of the study drug called pitolisant when compared with placebo (a tablet that does not contain any study drug) in treating some of the symptoms of Myotonic Dystrophy Type 1, such as excessive daytime sleepiness.
This study aims to learn more about: if an experimental medication called benralizumab could be effective and safe in treating EG/EGE and also to better understand the studied disease and associated health problems.
This is an early feasibility study looking at the safety, feasibility, and potential benefit of a medical device, called the NeuroPace RNS System, for people suffering from obesity, with uncontrolled eating habits.
The Women's Health Clinical Research Center at University of Pennsylvania is currently recruiting healthy women who have regular periods and do not wish to become pregnant for at least 12 months for a research study of an investigational birth control patch. The study patch that will be used in this …
Were doing this study to see how T-Guard works compared to ruxolitinib to treat aGVHD that doesnt get better with steroids. We want to know if T-Guard and ruxolitinib therapy will make aGVHD go away completely after 28 days.
This is a study to evaluate the efficacy and safety of Belzutifan monotherapy in participants with advanced pheochromocytoma/paraganglioma (PPGL) or pancreatic neuroendocrine tumor (pNET). The primary objective of the study is to evaluate the objective response rate (ORR) of belzutifan per Response Evaluation Criteria in Solid Tumors Version 1.1 (RECIST …
The purpose of this study is to continue to collect long term information on the safety of pembrolizumab or pembrolizumab-based combinations that you received or are receiving as part of the protocol you are currently enrolled in, to see how well the drug/s work and how your body reacts to …
Preeclampsia is a serious medical condition that can happen during pregnancy. It usually starts with increasing blood pressure and could affect liver, kidney or other organ functions. This study will to assess whether daily treatment with investigational drug pravastatin administered early in pregnancy reduces the rate of preeclampsia in high-risk …
